The platelets’ perspective to pathogen reduction technologies

Authors: Osman, Abdimajid; Hitzler, Walter E.; Provost, Patrick
Abstract: A wide variety of clinical conditions, associated with low circulating platelet counts, require platelet transfusion in order to normalize hemostatic function. Although single-donor apheresis platelets bear the lowest risk of transfusion-transmitted infections, pathogen reduction technologies (PRT) are being implemented worldwide to reduce this risk further through inactivation of known, emergent and as yet to be discovered nucleic acid-based pathogens. Human blood platelets are now known to harbor a diverse transcriptome, important to their function and comprised of >5000 protein-coding messenger RNAs and different classes of non-coding RNAs, including microRNAs. Our appreciation of the nucleic acid-dependent functions of platelets is likely to increase. On the other hand, the side effects of PRT on platelet function are underappreciated. Recent evidences suggest that PRT may compromise platelets’ responsiveness to agonists, and induce platelet activation. For instance, platelets have the propensity to release proinflammatory microparticles (MPs) upon activation, and the possibility that PRT may enhance the production of platelet MPs in platelet concentrates (PCs) appears likely. With this in mind, it would be timely and appropriate to investigate other means to inactivate pathogens more specifically, or to modify the currently available PRT so to better preserve the platelet function and improve the safety of PCs; platelets’ perspective to PRT deserves to be considered.
Document Type: Article de recherche
Issue Date: 29 March 2017
Open Access Date: Restricted access
Document version: VoR
This document was published in: Platelets, Vol. 29 (2), 140-147 (2018)
Informa Healthcare
Alternative version: 10.1080/09537104.2017.1293806
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
34 Osman et al. The platelets perspective to PRT Platelets 2018 copy 2.pdf
472.31 kBAdobe PDF    Request a copy
All documents in CorpusUL are protected by Copyright Act of Canada.